Cargando…

Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity

Aedes aegypti is a crucial vector for many arboviral diseases that cause millions of deaths worldwide and thus is of major public health concern. Crystal (Cry) proteins, which are toxins produced by Bacillus thuringiensis, are structurally organized into three-domains, of which domain II is the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Intikhab, Batool, Khadija, Idris, Aisha Lawan, Tan, Weilong, Guan, Xiong, Zhang, Lingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294448/
https://www.ncbi.nlm.nih.gov/pubmed/35865517
http://dx.doi.org/10.3389/fimmu.2022.906259
_version_ 1784749855952863232
author Alam, Intikhab
Batool, Khadija
Idris, Aisha Lawan
Tan, Weilong
Guan, Xiong
Zhang, Lingling
author_facet Alam, Intikhab
Batool, Khadija
Idris, Aisha Lawan
Tan, Weilong
Guan, Xiong
Zhang, Lingling
author_sort Alam, Intikhab
collection PubMed
description Aedes aegypti is a crucial vector for many arboviral diseases that cause millions of deaths worldwide and thus is of major public health concern. Crystal (Cry) proteins, which are toxins produced by Bacillus thuringiensis, are structurally organized into three-domains, of which domain II is the most variable in terms of binding towards various toxin receptors. The binding of Cry11Aa to putative receptor such as aminopeptidase-N (APN) is explicitly inhibited by midgut C-type lectins (CTLs). The similarity between the domain II fold of Cry11Aa toxin and the carbohydrate recognition domain in the CTLs is a possible structural basis for the involvement of Cry domain II in the recognition of carbohydrates on toxin receptors. In this study, a site-directed point mutation was introduced into the A. aegypti CTLGA9 gene on the basis of molecular docking findings, leading to substitution of the Leucine-6 (Leu-6) residue in the protein with alanine. Subsequently, functional monitoring of the mutated protein was carried out. Unlike the amino acid residues of wild-type CTLGA9, none of the residues of mutant (m) CTLGA9 were competed with Cry11Aa for binding to the APN receptor interface. Additionally, ligand blot analysis showed that both wild-type and mutant CTLGA9 had similar abilities to bind to APN and Cry11Aa. Furthermore, in the competitive ELISA in which labeled mutant CTLGA9 (10 nM) was mixed with increasing concentrations of unlabeled Cry11Aa (0–500 nM), the mutant showed no competition with Cry11Aa for binding to APN., By contrast, in the positive control sample of labeled wild type CTLGA9 mixed with same concentrations of Cry11Aa competition between the two ligands for binding to the APN was evident. These results suggest that Leucine-6 may be the key site involved in the competitive receptor binding between CTLGA9 and Cry11Aa. Moreover, according to the bioassay results, mutant CTLGA9 could in fact enhance the toxicity of Cry11Aa. Our novel findings provide further insights into the mechanism of Cry toxicity as well as a theoretical basis for enhancing the mosquitocidal activity of these toxin through molecular modification strategies.
format Online
Article
Text
id pubmed-9294448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92944482022-07-20 Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity Alam, Intikhab Batool, Khadija Idris, Aisha Lawan Tan, Weilong Guan, Xiong Zhang, Lingling Front Immunol Immunology Aedes aegypti is a crucial vector for many arboviral diseases that cause millions of deaths worldwide and thus is of major public health concern. Crystal (Cry) proteins, which are toxins produced by Bacillus thuringiensis, are structurally organized into three-domains, of which domain II is the most variable in terms of binding towards various toxin receptors. The binding of Cry11Aa to putative receptor such as aminopeptidase-N (APN) is explicitly inhibited by midgut C-type lectins (CTLs). The similarity between the domain II fold of Cry11Aa toxin and the carbohydrate recognition domain in the CTLs is a possible structural basis for the involvement of Cry domain II in the recognition of carbohydrates on toxin receptors. In this study, a site-directed point mutation was introduced into the A. aegypti CTLGA9 gene on the basis of molecular docking findings, leading to substitution of the Leucine-6 (Leu-6) residue in the protein with alanine. Subsequently, functional monitoring of the mutated protein was carried out. Unlike the amino acid residues of wild-type CTLGA9, none of the residues of mutant (m) CTLGA9 were competed with Cry11Aa for binding to the APN receptor interface. Additionally, ligand blot analysis showed that both wild-type and mutant CTLGA9 had similar abilities to bind to APN and Cry11Aa. Furthermore, in the competitive ELISA in which labeled mutant CTLGA9 (10 nM) was mixed with increasing concentrations of unlabeled Cry11Aa (0–500 nM), the mutant showed no competition with Cry11Aa for binding to APN., By contrast, in the positive control sample of labeled wild type CTLGA9 mixed with same concentrations of Cry11Aa competition between the two ligands for binding to the APN was evident. These results suggest that Leucine-6 may be the key site involved in the competitive receptor binding between CTLGA9 and Cry11Aa. Moreover, according to the bioassay results, mutant CTLGA9 could in fact enhance the toxicity of Cry11Aa. Our novel findings provide further insights into the mechanism of Cry toxicity as well as a theoretical basis for enhancing the mosquitocidal activity of these toxin through molecular modification strategies. Frontiers Media S.A. 2022-07-05 /pmc/articles/PMC9294448/ /pubmed/35865517 http://dx.doi.org/10.3389/fimmu.2022.906259 Text en Copyright © 2022 Alam, Batool, Idris, Tan, Guan and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Alam, Intikhab
Batool, Khadija
Idris, Aisha Lawan
Tan, Weilong
Guan, Xiong
Zhang, Lingling
Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity
title Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity
title_full Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity
title_fullStr Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity
title_full_unstemmed Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity
title_short Function of CTLGA9 Amino Acid Residue Leucine-6 in Modulating Cry Toxicity
title_sort function of ctlga9 amino acid residue leucine-6 in modulating cry toxicity
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294448/
https://www.ncbi.nlm.nih.gov/pubmed/35865517
http://dx.doi.org/10.3389/fimmu.2022.906259
work_keys_str_mv AT alamintikhab functionofctlga9aminoacidresidueleucine6inmodulatingcrytoxicity
AT batoolkhadija functionofctlga9aminoacidresidueleucine6inmodulatingcrytoxicity
AT idrisaishalawan functionofctlga9aminoacidresidueleucine6inmodulatingcrytoxicity
AT tanweilong functionofctlga9aminoacidresidueleucine6inmodulatingcrytoxicity
AT guanxiong functionofctlga9aminoacidresidueleucine6inmodulatingcrytoxicity
AT zhanglingling functionofctlga9aminoacidresidueleucine6inmodulatingcrytoxicity